The Effect of Gender and APOE ɛ4 Status on Brain Amyloid-β Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study
- PMID: 37334590
- DOI: 10.3233/JAD-221166
The Effect of Gender and APOE ɛ4 Status on Brain Amyloid-β Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study
Abstract
Background: Gender, APOE ɛ4 status and age have different effects on brain amyloid deposition in patients with mild cognitively impaired (MCI).
Objective: To investigate the effect of gender×APOE ɛ4 status interaction on Aβ deposition in the brains of individuals with MCI in different age groups by PET scanning.
Methods: 204 individuals with MCI were classified into younger or older groups based on whether they were under or over 65 years of age. APOE genotyping, structural MRI, amyloid PET scans, and neuropsychological tests were performed. The effect of gender×APOE ɛ4 status interaction on Aβ deposition was assessed in different age groups.
Results: APOE ɛ4 carriers had higher amyloid deposition than noncarriers in the whole group. Females with MCI had more amyloid deposition in the medial temporal lobe than males in the whole cohort and younger group. Older individuals with MCI had higher amyloid deposition than younger individuals. In stratified analysis by age, female APOE ɛ4 carriers had significantly increased amyloid deposition compared to their male counterparts only in the medial temporal lobe in the younger group. Amyloid deposition was increased in female APOE ɛ4 carriers compared to noncarriers in the younger group, whereas higher amyloid deposition was observed in male APOE ɛ4 carriers in the older group.
Conclusion: Women in the younger group with MCI who were APOE ɛ4 carriers had more amyloid deposition in the brain, while men in the older group with MCI who were APOE ɛ4 carriers had higher amyloid deposition.
Keywords: APOE; Alzheimer’s disease; PET; amyloid deposition; gender; mild cognitive impairment.
Similar articles
-
Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults.J Alzheimers Dis. 2022;89(3):1003-1016. doi: 10.3233/JAD-220427. J Alzheimers Dis. 2022. PMID: 35964194 Free PMC article.
-
Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.JAMA Neurol. 2018 Apr 1;75(4):488-494. doi: 10.1001/jamaneurol.2017.4325. JAMA Neurol. 2018. PMID: 29356823 Free PMC article.
-
Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.J Alzheimers Dis. 2016 Sep 6;54(2):559-68. doi: 10.3233/JAD-160395. J Alzheimers Dis. 2016. PMID: 27567846
-
Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.J Alzheimers Dis. 2016 Mar 29;52(3):849-61. doi: 10.3233/JAD-150900. J Alzheimers Dis. 2016. PMID: 27031472 Free PMC article.
-
Cognitive Improvement After Multi-Domain Lifestyle Interventions in an APOE ɛ4 Homozygous Carrier with Mild Cognitive Impairment: A Case Report and Literature Review.J Alzheimers Dis. 2022;89(4):1131-1142. doi: 10.3233/JAD-220374. J Alzheimers Dis. 2022. PMID: 35988223 Review.
Cited by
-
Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers.Alzheimers Dement. 2025 May;21(5):e70333. doi: 10.1002/alz.70333. Alzheimers Dement. 2025. PMID: 40432308 Free PMC article.
-
Positive rate and quantification of amyloid pathology with [18F]florbetapir in the urban Chinese population.Eur Radiol. 2024 May;34(5):3331-3341. doi: 10.1007/s00330-023-10366-z. Epub 2023 Oct 27. Eur Radiol. 2024. PMID: 37889270
-
Sex differences in amyloid PET in a large, real-world sample from the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study.Alzheimers Dement. 2025 May;21(5):e70304. doi: 10.1002/alz.70304. Alzheimers Dement. 2025. PMID: 40415175 Free PMC article.
-
Sex differences in the relationship between depression and Alzheimer's disease-mechanisms, genetics, and therapeutic opportunities.Front Aging Neurosci. 2024 Jun 5;16:1301854. doi: 10.3389/fnagi.2024.1301854. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38903903 Free PMC article. Review.
-
Tau pathology is associated with postsynaptic metabotropic glutamate receptor 5 (mGluR5) in early Alzheimer's disease in a sex-specific manner.Alzheimers Dement. 2025 Feb;21(2):e70004. doi: 10.1002/alz.70004. Alzheimers Dement. 2025. PMID: 39998900 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous